On and effective July 25, 2018, the board of directors of China Biologic Products Holdings, Inc. appointed each of Mr. Bing Li and Mr. Qi Ning as an independent director of the Board, and also appointed Mr. Qi Ning to serve on each of the Board’s Audit Committee, Compensation Committee and Governance and Nominating Committee. In addition, Mr. Joseph Chow was appointed as a member of the Governance and Nominating Committee. Mr. Zhijun Tong and Mr. Sean Shao ceased to be members of the Governance and Nominating Committee. Mr. David Hui Li. Mr. Li has been a member of its Board since November 4, 2013 and its Chairman since July 2018. Mr. Li is also the founder and chief executive officer of Centurium Capital. Mr. Li was an executive director and a managing director at Warburg Pincus Asia LLC from February 2002 to January 2016. Zhijun Tong. Mr. Tong has been a member of its Board since April 20, 2012, and its acting CEO in the interim from July 2018. He has served on many boards of directors, including as chairman of the board. Mr. Shao currently serves as (i) independent director and chairman of the audit committee of 21Vianet Group, Inc. Mr. Yungang Lu. has been a member of its Board since March 19, 2012. Dr. Lu is a Managing Partner of Fort Hill Capital Limited Joseph Chow. Mr. Chow has been a member of its Board since November 3, 2014. Mr. Chow has over 20 years of experience in corporate finance, financial advisory and management and has held senior executive and managerial positions in various public and private companies. Ms. Yue’e Zhang was appointed as a director on its Board on January 1, 2018, pursuant to the investor rights agreement dated as of January 1, 2018 by and between the Company and PW Medtech Group Limited, a major shareholder of the Company. Mr. Li has been a member of its Board since July 25, 2018 and previously served on its board from February 2011 to May 2014. Mr. Li served as a managing director of Fosun Group, a Chinese international conglomerate and investment company, from March 2016 to December 2017 and a vice president of Shanghai Fosun Pharmaceutical (Group) Co., Ltd, from May 2014 to February 2016. Mr. Ning has been a member of its Board since July 25, 2018. Mr. Ning has been an executive director and chief executive officer of Sinnet Cloud Data Co. Ltd., a company specializing in marketing and promoting AWS cloud products and related services in China, since May 2018.